IT1243341B - PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS - Google Patents

PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS

Info

Publication number
IT1243341B
IT1243341B IT02094390A IT2094390A IT1243341B IT 1243341 B IT1243341 B IT 1243341B IT 02094390 A IT02094390 A IT 02094390A IT 2094390 A IT2094390 A IT 2094390A IT 1243341 B IT1243341 B IT 1243341B
Authority
IT
Italy
Prior art keywords
inflammators
pharmaceutical composition
oral use
modified release
steroid anti
Prior art date
Application number
IT02094390A
Other languages
Italian (it)
Other versions
IT9020943A1 (en
IT9020943A0 (en
Inventor
Ubaldo Conte
Original Assignee
Farcon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farcon Ag filed Critical Farcon Ag
Publication of IT9020943A0 publication Critical patent/IT9020943A0/en
Priority to IT02094390A priority Critical patent/IT1243341B/en
Priority to PCT/EP1991/001246 priority patent/WO1992000730A1/en
Priority to AU81862/91A priority patent/AU8186291A/en
Priority to ES91912626T priority patent/ES2043567T1/en
Priority to DE1991912626 priority patent/DE491911T1/en
Priority to EP19910912626 priority patent/EP0491911A1/en
Priority to CA002066751A priority patent/CA2066751A1/en
Publication of IT9020943A1 publication Critical patent/IT9020943A1/en
Priority to GR930300020T priority patent/GR930300020T1/el
Application granted granted Critical
Publication of IT1243341B publication Critical patent/IT1243341B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT02094390A 1990-07-13 1990-07-13 PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS IT1243341B (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT02094390A IT1243341B (en) 1990-07-13 1990-07-13 PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS
DE1991912626 DE491911T1 (en) 1990-07-13 1991-07-04 PHARMACEUTICAL PREPARATION FOR NON-STEROIDANT ANTI-INFLAMMATORY PRODUCTS FOR ORAL USE WITH DELAYED RELEASE.
AU81862/91A AU8186291A (en) 1990-07-13 1991-07-04 A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
ES91912626T ES2043567T1 (en) 1990-07-13 1991-07-04 A CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING NON-STEROID ANTI-INFLAMMATORY DRUGS.
PCT/EP1991/001246 WO1992000730A1 (en) 1990-07-13 1991-07-04 A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
EP19910912626 EP0491911A1 (en) 1990-07-13 1991-07-04 A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
CA002066751A CA2066751A1 (en) 1990-07-13 1991-07-04 Controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs
GR930300020T GR930300020T1 (en) 1990-07-13 1993-04-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02094390A IT1243341B (en) 1990-07-13 1990-07-13 PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS

Publications (3)

Publication Number Publication Date
IT9020943A0 IT9020943A0 (en) 1990-07-13
IT9020943A1 IT9020943A1 (en) 1992-01-13
IT1243341B true IT1243341B (en) 1994-06-10

Family

ID=11174413

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02094390A IT1243341B (en) 1990-07-13 1990-07-13 PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS

Country Status (7)

Country Link
EP (1) EP0491911A1 (en)
AU (1) AU8186291A (en)
CA (1) CA2066751A1 (en)
ES (1) ES2043567T1 (en)
GR (1) GR930300020T1 (en)
IT (1) IT1243341B (en)
WO (1) WO1992000730A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
US5922722A (en) * 1996-11-12 1999-07-13 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
DE19718012C1 (en) * 1997-04-29 1998-10-08 Jenapharm Gmbh Process for the production of orally applicable solid pharmaceutical forms with controlled release of active substances
DE19901683B4 (en) * 1999-01-18 2005-07-21 Grünenthal GmbH Controlled-release analgesic
EP2070520A1 (en) 2007-12-11 2009-06-17 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2021147A1 (en) * 1970-04-30 1971-11-11 Christian Brunnengraeber Chem Medicinal capsule contg separate units
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
IT1230576B (en) * 1988-10-20 1991-10-28 Angeli Inst Spa ORAL PHARMACEUTICAL FORMULATIONS WITH SELECTIVE LIBERATION IN THE COLON

Also Published As

Publication number Publication date
AU8186291A (en) 1992-02-04
CA2066751A1 (en) 1992-01-14
ES2043567T1 (en) 1994-01-01
IT9020943A1 (en) 1992-01-13
GR930300020T1 (en) 1993-04-28
WO1992000730A1 (en) 1992-01-23
IT9020943A0 (en) 1990-07-13
EP0491911A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
BR8902339A (en) COMPOSITION FOR ORAL USE
NO924183D0 (en) PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE
ITBO910113A0 (en) CASTRO-RESISTANT PHARMACEUTICAL FORMULATIONS FOR ORAL USE CONTAINING BILE ACIDS
FI913410A7 (en) Sustained release pharmaceutical compositions
FI944165L (en) Composition for oral preparations
FI20050991L (en) Use of a compound containing a sulfamate group for the preparation of steroid sulfatase inhibitors
ATA129892A (en) PHARMACEUTICAL COMPOSITION
FI922316L (en) PHARMACEUTICAL COMPOSITION
FI981777A0 (en) Pharmaceutical composition
FI925661L (en) INJICERBAR PHARMACEUTICAL COMPOSITION
IT1231012B (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING NAC.
NO20041007L (en) Use of oxypurine nucleosides for the preparation of a pharmaceutical composition
FI910088A7 (en) Oral pharmaceutical composition
FI944534A0 (en) Rapamycin compositions for oral administration
FI944535L (en) Rapamycin compositions for oral administration
DE4294862T1 (en) Pharmaceutical composition
ITTO920303A0 (en) "ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION"
EE9400257A (en) Use of a Quinoline-3-carboxamide compound for the preparation of a pharmaceutical composition
UA26064A1 (en) PHARMACEUTICAL COMPOSITION
IT1243341B (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE WITH MODIFIED RELEASE OF NON STEROID ANTI-INFLAMMATORS
BR9305203A (en) Use of a compound in the preparation of a medication
ITMI913510A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH-BIOAVAILABILITY PROGESTERONE
IT8721981A0 (en) ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION WITH LONG-LASTING EFFECT FOR TOPICAL USE
IT9021021A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HIRUDIN
IT8521214A0 (en) SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729